An inflammation researcher at The University of Manchester is set to establish a world-class research program that aims to shed new light on rheumatoid arthritis, after becoming the first ever awardee of a £2.5 million Kennedy Trust Senior Fellowship.
Congratulations to Professor David Felson, Programme Lead in the BRC’s Musculoskeletal Theme, who was awarded the prestigious Carol-Nachman Prize for rheumatology at a recent awards ceremony in Germany.
The Public Programmes Team, which leads on PPIE within the BRC and CRF, has secured a five year award from the Wellcome Trust Sustaining Excellence grant scheme following a rigorous and by invitation only review process.
At the beginning of April BRC researchers presented and exhibited at the business of precision medicine – visioning the future event in Leeds, jointly organised by the NHSA and BioNow.
Manchester Molecular Pathology Innovation Centre is holding the second of its exciting industry workshops on Thursday 8th June 10.00am- 4.00pm
Manchester is part of a new consortium which will develop new CT and MRI scan techniques and biomarkers to look at the accumulation of compounds in the body caused by drugs and the harm they may cause – potentially improving patients’ safety and the development of new treatments.
Two new publications, supported by the NIHR Manchester Musculoskeletal Biomedical Research Unit, provide new information that could help better diagnosis and treatment of Inclusion Body Myositis (IBM), a rare musculoskeletal condition.
Five research theme leads from the Musculoskeletal BRU have been included in a list of the top 30 most cited rheumatology authors in the Europe.